These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8673999

  • 21. Treatment of stage IIIB non-small-cell lung cancer with surgery followed by infusion of tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
    Melioli G, Ratto GB, Ponte M, Guastella M, Semino C, Fantino G, Tassara E, Pasquetti W, Mereu C, Merlo F, Reggiardo G, Morasso G, Santi L, Moretta L.
    J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):224-30. PubMed ID: 8811497
    [Abstract] [Full Text] [Related]

  • 22. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy.
    Little AG, DeMeester TR, Ferguson MK, Skinner DB, Hoffman PC, Skosey C, Blough RR, Golomb HM.
    Surgery; 1986 Oct; 100(4):621-8. PubMed ID: 3020725
    [Abstract] [Full Text] [Related]

  • 23. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM.
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
    [Abstract] [Full Text] [Related]

  • 24. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H.
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W, Li Y, Shen L, Cai XW, Zhu ZF, Chang JH, Xiang JQ, Zhang YW, Chen HQ, Fu XL.
    Oncotarget; 2016 Feb 09; 7(6):7227-40. PubMed ID: 26811495
    [Abstract] [Full Text] [Related]

  • 31. Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study.
    Ratto GB, Costa R, Maineri P, Alloisio A, Piras MT, D'Agostino A, Tripodi G, Rivabella L, Dozin B, Bruzzi P, Melioli G.
    Int J Immunopathol Pharmacol; 2011 Feb 09; 24(4):1005-16. PubMed ID: 22230406
    [Abstract] [Full Text] [Related]

  • 32. Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors.
    Kilic A, Landreneau RJ, Luketich JD, Pennathur A, Schuchert MJ.
    J Surg Res; 2011 May 15; 167(2):207-10. PubMed ID: 19896677
    [Abstract] [Full Text] [Related]

  • 33. [Guide line for the treatment of stage I and stage II non small cell lung cancer].
    Kobayashi K.
    Nihon Geka Gakkai Zasshi; 2004 Jul 15; 105(7):392-403. PubMed ID: 15303438
    [Abstract] [Full Text] [Related]

  • 34. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T, Azuma K, Kawahara A, Ishii H, Yamada K, Matsuo N, Kinoshita T, Mizukami N, Ono H, Kage M, Hoshino T.
    Eur J Cancer; 2016 Mar 15; 55():7-14. PubMed ID: 26771872
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.